Skip to main content
Toggle navigation
Login
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Pacewicz, Klaudia
Intelliseq
Precision, Context, and Control: iFlow’s New Tools for Oncology & Variant Curation
Location: Innovation Spotlight Stage #2
Klaudia Pacewicz
Pai, Emily Ling-Lin
Hospital of the University of Pennsylvania
Beyond the Classics: The Spectrum of NPM1 Mutations
Location: 156ABC, Level 1
Emily Ling-Lin Pai
Pal, PhD, Prithwish
Biodesix & New Approaches to Comprehensive Molecular Testing: Focus on Accurate Results with Rapid Turn-around, High-throughput and Low Sample Requirements for Diagnosis and Monitoring
Location: 156C, Level 1
Prithwish Pal, PhD
Palathingal Bava, Ejas
Washington University, St. Louis
Automate to Innovate: Practical Insights for Molecular Diagnostics Through Engineering Efficiency and Smart Automation
Location: 258ABC, Level 2
Ejas Palathingal Bava
Pantel, Klaus
UKE Hamburg Germany
MRD’s Next Decade: Improving Accuracy and Precision of Tumor-Informed MRD to Standardizing Epigenetics and Fragmentomics for Tumor Agnostic MRD
Location: 152, Level 1
Klaus Pantel
Parikh, Aparna R.
Harvard Medical School
Demystifying MRD with BloodPac: Navigating Clinical and Technical Pathways for Comprehensive Cancer Monitoring
Location: 156AB, Level 1
Aparna R. Parikh
Molecular Residual Disease (MRD): The Current Landscape, Key Challenges, and Future Opportunities
Location: 160B, Level 1
Aparna R. Parikh
Park, Kyung
NYU Grossman School of Medicine
New Paradigms for Diagnosis of CNS tumors, Sarcomas, and Kidney tumors utilizing AI-driven DNA Methylations Classifiers
Location: 159, Level 1
Kyung Park
Patel, Jai
Atrium Health Levine Cancer Institute
Guideline-Driven PGx Testing: A new, targeted testing approach covering all AMP Tier 1 and Tier 2 pharmacogenomic recommendations.
Location: 159, Level 1
Jai Patel
Precision Oncology in Practice: Relevance of DPYD Genotyping and Implementation of Rapid Methylation, Lung and AML Panels for faster results.
Location: 159, Level 1
Jai Patel
Patel, Jay
University of Utah and ARUP Laboratories
Understanding long-term PAMA Reform: a look at the RESULTS Act
Location: Innovation Spotlight Stage #3
Jay Patel
Patel, Keyur
University of Texas MD Anderson Cancer Center
AMP Working Group: Molecular Testing for Measurable Residual Disease Testing in Acute Myeloid Leukemia
Location: 156ABC, Level 1
Keyur Patel
Bots on the Bench: Real-World Lessons from Custom Automation in Molecular Diagnostics
Location: 258ABC, Level 2
Keyur Patel
Patel, Lalit
Emory University
From Targeted NGS Panels to Virtual Panels in the Era of Exome Sequencing
Location: 153ABC, Level 1
Lalit Patel
Patel, Nirali
Tempus Labs
Innovating Pathology Together: Real-World Applications of Digital Pathology and AI-Driven Algorithms
Location: 154, Level 1
Nirali Patel
Pattani, Varun
Foundation Medicine
MRD’s Next Decade: Improving Accuracy and Precision of Tumor-Informed MRD to Standardizing Epigenetics and Fragmentomics for Tumor Agnostic MRD
Location: 152, Level 1
Varun Pattani
Patterson, Sara
Revealing the Value of Literature-Based Real-World Evidence: Transforming Trial Design, Label Expansion, and Clinical Decision-Making
Location: 156AB, Level 1
Sara Patterson
Pawlowski, Traci
Illumina
Demystifying MRD with BloodPac: Navigating Clinical and Technical Pathways for Comprehensive Cancer Monitoring
Location: 156AB, Level 1
Traci Pawlowski
Pekosz, Andrew
Johns Hopkins Bloomberg School of Public Health
Emerging Public Health Threats - Avian Influenza A(H5N1)
Location: 157ABC, Level 1
Andrew Pekosz
Pendse, Ninad
Asuragen, a Bio-Techne brand
Breaking Barriers in Carrier Screening and Beyond: Unlocking Complex Variants with AmplideX Enrichment and Long-Read Sequencing
Location: 153B, Level 1
Ninad Pendse
Pestano, PhD, Gary
Biodesix & New Approaches to Comprehensive Molecular Testing: Focus on Accurate Results with Rapid Turn-around, High-throughput and Low Sample Requirements for Diagnosis and Monitoring
Location: 156C, Level 1
Gary Pestano, PhD
Implementing Droplet Digital PCR (ddPCR) in the Lab: Practical Strategies for MRD and Monitoring
Location: 157C, Level 1
Gary Pestano, PhD
Petersen, Caroline
10x Genomics
Bridging Molecular Pathology With Single Cell Multiomics
Location: 154, Level 1
Caroline Petersen
Peterson, Jason
Velsera
Streamlining Clinical Genomics Workflows: Accelerated Case Review Across Germline and Somatic Indications
Location: 157AB, Level 1
Jason Peterson
Pilie, Patrick
MD Anderson Cancer Center
Putting Precision Medicine into Practice for Prostate Cancer: Impact of Genetic Testing on Cancer Risk and Treatment
Location: 156ABC, Level 1
Patrick Pilie
Pillei, Sugganth
NeoGenomics
Liquid Biopsy at Scale: Clinical Evidence for Next-Generation CGP
Location: 158, Level 1
Sugganth Pillei
Pinsky, Benjamin
Stanford University School of Medicine
Emerging Public Health Threats - Re-Emerging Vaccine-Preventable Infectious Diseases
Location: 157ABC, Level 1
Benjamin Pinsky
Pireyre, Marie
SeqOne
Next-Generation Comprehensive Genomic Profiling — A Streamlined Workflow with Twist and SeqOne
Location: Innovation Spotlight Stage #3
Marie Pireyre
Post, Corey
University of Michigan
(H028) Addition of a Targeted Gene Fusion Assay into Myeloid NGS Enables Detection of Cytogenetically Cryptic, Disease-Defining AML Gene Fusions
Corey Post
Pratt, Vicky
Agena Bioscience
AMP Guideline Essentials:
DPYD Genotyping Recommendations
Location: Innovation Spotlight Stage #3
Vicky Pratt
Confidence in Every Result: Tools & Insights for Molecular Lab Success
Location: 157C, Level 1
Vicky Pratt
Guideline-Driven PGx Testing: A new, targeted testing approach covering all AMP Tier 1 and Tier 2 pharmacogenomic recommendations.
Location: 159, Level 1
Vicky Pratt
Priore, Salvatore
University of Pennsylvania
Future-Proof Your Genomics Journey
Location: 158, Level 1
Salvatore Priore
Przygodzki, Ronald
Recent Key Advances in Molecular Diagnostics
Location: Innovation Spotlight Stage #1
Ronald Przygodzki
Pugh, Trevor
Princess Margaret Cancer Centre / Ontario Institute for Cancer Research
Enabling Precision Oncology with Ultra-Deep whole-genome Sequencing and Integrated Methylation Profiling of cfDNA
Location: 160B, Level 1
Trevor Pugh
Revolutionizing Oncology: Advancements and Impact of Cell-Free DNA Testing in Precision Cancer Care
Location: 153ABC, Level 1
Trevor Pugh
